Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors

被引:586
作者
Sitkovsky, MV [1 ]
Lukashev, D [1 ]
Apasov, S [1 ]
Kojima, H [1 ]
Koshiba, M [1 ]
Caldwell, C [1 ]
Ohta, A [1 ]
Thiel, M [1 ]
机构
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
关键词
hypoxia; adenosine receptors; immunity; inflammation;
D O I
10.1146/annurev.immunol.22.012703.104731
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immune cell-mediated destruction of pathogens may result in excessive collateral damage to normal tissues, and the failure to control activated immune cells may cause inummopathologies. The search for physiological mechanisms that down-regulate activated immune cells has revealed a critical role for extracellular adenosine and for immuno suppressive A(2A) adenosine receptors in protecting tissue from inflammatory damage. Tissue damage-associated deep hypoxia, hypoxia-inducible factors, and hypoxia-induced accumulation of adenosine may represent one of the most fundamental and immediate tissue-protecting mechanisms, with adenosine A(2A) receptors triggering "OFF" signals in activated immune cells. In these regulatory mechanisms, oxygen deprivation and extracellular adenosine accumulation serve as "reporters," while A(2A) adenosine receptors serve as "sensors" of excessive tissue damage. The A(2A) receptor-triggered generation of intracellular cAMP then inhibits activated immune cells in a delayed negative feedback manner to prevent additional tissue damage. Targeting A(2A) adenosine receptors may have important clinical applications.
引用
收藏
页码:657 / 682
页数:26
相关论文
共 120 条
[1]   Aggravated brain damage after hypoxic ischemia in immature adenosine A2A knockout mice [J].
Ådén, U ;
Halldner, L ;
Lagercrantz, H ;
Dalmau, I ;
Ledent, C ;
Fredholm, BB .
STROKE, 2003, 34 (03) :739-744
[2]  
Aldrich MB, 2000, ADV EXP MED BIOL, V486, P57
[3]  
Apasov S, 2000, BLOOD, V95, P3859
[4]   The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase [J].
Apasov, SG ;
Sitkovsky, MV .
INTERNATIONAL IMMUNOLOGY, 1999, 11 (02) :179-189
[5]  
Apasov SG, 1997, J IMMUNOL, V158, P5095
[6]   Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling [J].
Apasov, SG ;
Blackburn, MR ;
Kellems, RE ;
Smith, PT ;
Sitkovsky, MV .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (01) :131-141
[7]   Study of A2A adenosine receptor gene deficient mice reveals that adenosine analogue CGS 21680 possesses no A2A receptor-unrelated lymphotoxicity [J].
Apasov, SG ;
Chen, JF ;
Smith, PT ;
Schwarzschild, MA ;
Fink, JS ;
Sitkovsky, MV .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (01) :43-50
[8]  
ARFORS KE, 1987, BLOOD, V69, P338
[9]   Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes:: studies of cells from A2A-receptor-gene-deficient mice [J].
Armstrong, JM ;
Chen, JF ;
Schwarzschild, MA ;
Apasov, S ;
Smith, PT ;
Caldwell, C ;
Chen, P ;
Figler, H ;
Sullivan, G ;
Fink, S ;
Linden, J ;
Sitkovsky, M .
BIOCHEMICAL JOURNAL, 2001, 354 :123-130
[10]   Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A3 adenosine receptor antagonists [J].
Baraldi, PG ;
Cacciari, B ;
Moro, S ;
Spalluto, G ;
Pastorin, G ;
Da Ros, T ;
Klotz, KN ;
Varani, K ;
Gessi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :770-780